Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Melanoma HELP
Based on 34,116 articles published since 2008
|||| 19 

These are the 34116 published articles about Melanoma that originated from Worldwide during 2008-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
276 Editorial Molecular biomarkers of prognosis in melanoma: how far are we from the clinic? 2013

Schramm, Sarah-Jane / Menzies, Alexander M / Mann, Graham J. ·aThe University of Sydney at Westmead Millennium Institute for Medical Research bMelanoma Institute Australia, Sydney, New South Wales, Australia. ·Melanoma Res · Pubmed #24165033.

ABSTRACT: -- No abstract --

277 Editorial Kinase inhibitors and immune check-point blockade for the treatment of metastatic melanoma and advanced cancer: synergistic or antagonistic? 2013

Luke, Jason John / Ott, Patrick Alexander. ·Dana-Farber Cancer Institute, Harvard Medical School, Melanoma Disease Center, Early Drug Development Center, Center for Immuno Oncology , 450 Brookline Ave, Boston, MA 02215 , USA +1 6176324715 ; +1 6176326727 ; Jason_luke@dfci.harvard.edu. ·Expert Opin Pharmacother · Pubmed #24138302.

ABSTRACT: In recent years, therapeutic approaches for many tumors have broadened or even shifted entirely from cytotoxic chemotherapy to specific targeting of dysregulated proteins (predominately kinases), and more recently, harnessing of the anti-tumor immune response. The most prominent example of this shift is the management of metastatic melanoma, where BRAF and MEK inhibition and CLTA-4 blockade have established an entirely new standard of care in the last 3 years. Targeted kinase inhibition and immune checkpoint blockade have different strengths and weaknesses. Kinase inhibitors generally have rapid and impressive response rates but modest progression-free survival while immunotherapy can achieve durable tumor control, but is often associated with lower response rates and slower time to clinical benefit. These approaches would seem to be complementary however the results of early combination studies suggest that caution is advised when combining targeted kinase inhibition with immunotherapy. In this context, rigorous biomarker driven clinical trials are needed to further elucidate mechanisms of both benefit and toxicity. Depending on disease specific biology, it seems likely that both combination and sequential approaches of kinase inhibitors with immunotherapy will be required in order to harness the full potential of these approaches.

278 Editorial A sea change in melanoma. 2013

Bates, Susan E. · ·Clin Cancer Res · Pubmed #24089440.

ABSTRACT: -- No abstract --

279 Editorial Recent advances in the treatment of melanoma. 2013

Zager, Jonathan S / Sarnaik, Amod A / Gibney, Geoffrey T / Kudchadkar, Ragini R. ·Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA. Jonathan.Zager@Moffitt.org. ·Cancer Control · Pubmed #24077400.

ABSTRACT: -- No abstract --

280 Editorial Acral melanoma: a unique disease in Asia. 2013

Chang, John Wen-Cheng. ·Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan. ·JAMA Dermatol · Pubmed #24068331.

ABSTRACT: -- No abstract --

281 Editorial On the cusp of a revolution: melanoma molecular diagnostics. 2013

Carlson, John Andrew. ·Divisions of Dermatology and Dermatopathology, Albany Medical College, Albany, New York. Electronic address: carlsoa@mail.amc.edu. ·J Am Acad Dermatol · Pubmed #24034371.

ABSTRACT: -- No abstract --

282 Editorial Is pediatric melanoma always malignant? 2013

Coit, Daniel G / Ernstoff, Marc S / Busam, Klaus J. ·Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York. ·Cancer · Pubmed #24022827.

ABSTRACT: -- No abstract --

283 Editorial Malignant melanoma and epidermolysis bullosa simplex. 2013

Fine, Jo-David. ·Departments of Medicine (Dermatology) and Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee. ·JAMA Dermatol · Pubmed #23966137.

ABSTRACT: -- No abstract --

284 Editorial Sunbeds and young people: an easy target for legislation? 2013

Diffey, B. · ·Br J Dermatol · Pubmed #23941246.

ABSTRACT: -- No abstract --

285 Editorial Too much surgery and too little benefit? Sentinel node biopsy for melanoma as it currently stands. 2013

McGregor, J M. · ·Br J Dermatol · Pubmed #23941245.

ABSTRACT: -- No abstract --

286 Editorial Another option in our KIT of effective therapies for advanced melanoma. 2013

Carvajal, Richard D. ·Memorial Sloan-Kettering Cancer Center, New York, NY. ·J Clin Oncol · Pubmed #23940226.

ABSTRACT: -- No abstract --

287 Editorial Improving apoptotic responses to targeted therapy. 2013

Haq, Rizwan / Fisher, David E. ·Department of Dermatology, Massachusetts General Hospital. ·Oncotarget · Pubmed #23934756.

ABSTRACT: -- No abstract --

288 Editorial Radiation lays down covering fire for viral shock troops. 2013

Kyula, Joan N / Khan, Aadil A / Wilkinson, Michelle J / Mansfield, David / Harrington, Kevin J. ·Department of cancer biology, Institute of Cancer Research, London. ·Oncotarget · Pubmed #23912566.

ABSTRACT: -- No abstract --

289 Editorial Levels of evidence in canine oncology trials--a case in point. 2013

Vail, David M. · ·Vet Comp Oncol · Pubmed #23909995.

ABSTRACT: -- No abstract --

290 Editorial [Editorial]. 2013

Bornfeld, N / Bechrakis, N E / Auw-Hädrich, C. · ·Klin Monbl Augenheilkd · Pubmed #23877819.

ABSTRACT: -- No abstract --

291 Editorial A plea for biobanking of all equivocal melanocytic proliferations. 2013

Soyer, H Peter / Lin, Lynlee L / Prow, Tarl W. ·Dermatology Research Centre, The University of Queensland, School of Medicine, Translational Research Institute, Brisbane, Queensland, Australia2Department of Dermatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia. ·JAMA Dermatol · Pubmed #23864136.

ABSTRACT: -- No abstract --

292 Editorial Skin cancer treatment options: new horizons and promises for the future. 2013

Semkova, Kristina / Tchernev, Georgi / Wollina, Uwe. · ·Wien Med Wochenschr · Pubmed #23846703.

ABSTRACT: -- No abstract --

293 Editorial The potential for targeting the STAT3 pathway as a novel therapy for melanoma. 2013

Lesinski, Gregory B. · ·Future Oncol · Pubmed #23837753.

ABSTRACT: -- No abstract --

294 Editorial Disproportionate burden of melanoma mortality in young U.S. men: the possible role of biology and behavior. 2013

Fisher, David E / Geller, Alan C. ·Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, Boston. ·JAMA Dermatol · Pubmed #23804228.

ABSTRACT: -- No abstract --

295 Editorial The immune system in pigment cell biology: villain or hero? 2013

Kelsh, Robert / Arnheiter, Heinz / Bosenberg, Marcus. · ·Pigment Cell Melanoma Res · Pubmed #23800272.

ABSTRACT: -- No abstract --

296 Editorial [Malignant heart neoplasms]. 2013

Gregor, P. · ·Vnitr Lek · Pubmed #23795367.

ABSTRACT: -- No abstract --

297 Editorial Surgical removal of intraocular tumors: dismissing old wives' tales. 2013

Shields, Carol L / Shields, Jerry A. · ·Am J Ophthalmol · Pubmed #23791370.

ABSTRACT: -- No abstract --

298 Editorial [Screening for sentinel nodes in melanoma: medical rationale and professional ethics]. 2013

Lipsker, D. · ·Ann Dermatol Venereol · Pubmed #23773738.

ABSTRACT: -- No abstract --

299 Editorial [Update and review of conjunctival melanoma treatment]. 2013

Satué Palacián, M / Garcia-Martin, E / Fernández Tirado, F J / Pablo Júlvez, L E. · ·Arch Soc Esp Oftalmol · Pubmed #23768470.

ABSTRACT: -- No abstract --

300 Editorial Potential pitfalls in measuring the thickness of small choroidal melanocytic tumors with ultrasonography. 2013

Mrejen, Sarah / Fung, Adrian T / Silverman, Ronald H / Kendall, Cynthia / Freund, K Bailey. · ·Retina · Pubmed #23751944.

ABSTRACT: -- No abstract --

Back · Next